Sulbentine
Chemical compound
- D01AE09 (WHO)
- 3,5-bis(phenylmethyl)-1,3,5-thiadiazinane-2-thione
- 350-12-9 Y
- 67686
- 61005 N
- D0NR12WK9J
- D01335 Y
- DTXSID7046257
- Interactive image
- c1ccc(cc1)CN2CN(C(=S)SC2)Cc3ccccc3
InChI
- InChI=1S/C17H18N2S2/c20-17-19(12-16-9-5-2-6-10-16)13-18(14-21-17)11-15-7-3-1-4-8-15/h1-10H,11-14H2 N
- Key:QFVAWNPSRQWSDU-UHFFFAOYSA-N N
Sulbentine (or dibenzthione) is an antifungal.[1]
References
- ^ Hänel H, Raether W, Dittmar W (1988). "Evaluation of fungicidal action in vitro and in a skin model considering the influence of penetration kinetics of various standard antimycotics". Annals of the New York Academy of Sciences. 544 (1): 329–37. Bibcode:1988NYASA.544..329H. doi:10.1111/j.1749-6632.1988.tb40417.x. PMID 3214073. S2CID 13183316.
- v
- t
- e
Antifungals (D01 and J02)
membrane
Ergosterol inhibitors |
| ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
β-glucan synthase inhibitors |
Pyrimidine analogues/ thymidylate synthase inhibitors |
|
---|---|
Mitotic inhibitors |
|
Aminoacyl tRNA synthetase inhibitors |
|
- bromochlorosalicylanilide
- chlorophetanol
- chlorphenesin
- ciclopirox
- crystal violet
- dimazole
- ethylparaben
- haloprogin‡
- polynoxylin
- potassium iodide#
- salicylic acid
- selenium disulfide#
- sodium thiosulfate#
- sulbentine
- taurolidine
- ticlatone
- tolciclate
- tolnaftate
- tribromometacresol
- undecylenic acid
- Whitfield's ointment#
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This dermatologic drug article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e